JP3207000005
JP3207000005
KAKEN PHARMACEUTICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q1 '26 31.03.2026 |
|---|---|---|
Market & Enterprise Value | ||
Market Cap | 140.3B EUR | 160.18B EUR |
Enterprise Value | 86.01B EUR | 119.32B EUR |
Valuation Multiples | ||
Trailing P/E | 65.68x | -- |
Forward P/E | 38.43x | -- |
Price to Sales | 1.59x | -- |
Price to Book | 0.92x | 1.09x |
EV/Revenue | 0.98x | -- |
EV/EBITDA | 6.37x | -- |
Price to FCF (P/FCF) | -- | -- |
EV/FCF | -- | -- |
FCF Yield | -- | -- |